FGF-2- and TGF-β1-induced downregulation of lumican and keratocan in activated corneal keratocytes by JNK signaling pathway

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8957-8964

  Chen, Jian ^a   Wong Chong, Julie ^a   SundarRaj, Nirmala ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; KERATOCAN; LUMICAN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; EYE PROTEIN; KERATAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE 9; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORNEA CELL; CORNEA STROMA; IMMUNOCYTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; WOUND HEALING;

ANIMALS; ANTHRACENES; CELLS, CULTURED; CHONDROITIN SULFATE PROTEOGLYCANS; CORNEAL KERATOCYTES; CORNEAL STROMA; DOWN-REGULATION; EYE PROTEINS; FIBROBLAST GROWTH FACTOR 2; KERATAN SULFATE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PHENOTYPE; PROTEOGLYCANS; RABBITS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84862832904     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8078     Document Type: Article

References (36)

1. Benedek GB. Theory of transparency of the eye. Appl Opt. 1971; 10:459-473.
2. Meek KM, Boote C. The organization of collagen in the corneal stroma. Exp Eye Res. 2004;78:503-512.
3. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res. 2010;91:326-335.
4. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998;141: 1277-1286.
5. Chakravarti S, Petroll WM, Hassell JR, et al. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Invest Ophthalmol Vis Sci. 2000;41:3365-3373.
6. Chakravarti S. Functions of lumican and fibromodulin: lessons from knockout mice 1. Glycoconj J. 2002;19:287-293.
7. Kao WW, Liu CY. Roles of lumican and keratocan on corneal transparency 1. Glycoconj J. 2002;19:275-285.
8. Liu CY, Birk DE, Hassell JR, Kane B, Kao WW. Keratocan-deficient mice display alterations in corneal structure. J Biol Chem. 2003; 278:21672-21677.
9. Chakravarti S, Zhang G, Chervoneva I, Roberts L, Birk DE. Collagen fibril assembly during postnatal development and dysfunctional regulation in the lumican-deficient murine cornea 1. Dev Dyn. 2006;235:2493-2506.
10. Ahmadi AJ, Jakobiec FA. Corneal wound healing: cytokines and extracellular matrix proteins. Int Ophthalmol Clin. 2002;42:13-22.
11. Baldwin HC, Marshall J. Growth factors in corneal wound healing following refractive surgery: a review. Acta Ophthalmol Scand. 2002;80:238-247.
12. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
13. Nishida T, Tanaka T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol. 1996;7:2-11.
14. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999;18:529-551.
15. Funderburgh JL, Cintron C, Covington HI, Conrad GW. Immunoanalysis of keratan sulfate proteoglycan from corneal scars. Invest Ophthalmol Vis Sci. 1988;29:1116-1124.
16. Sundar Raj N, Fite D, Belak R, et al. Proteoglycan distribution during healing of corneal stromal wounds in chick 266. Exp Eye Res. 1998;67:433-442.
17. Brown CT, Applebaum E, Banwatt R, Trinkaus-Randall V. Synthesis of stromal glycosaminoglycans in response to injury. J Cell Biochem. 1995;59:57-68.
18. Carlson EC, Wang IJ, Liu CY, Brannan P, Kao CW, Kao WW. Altered KSPG expression by keratocytes following corneal injury. Mol Vis. 2003;9:615-623.
19. Funderburgh JL, Funderburgh ML, Mann MM, Prakash S, Conrad GW. Synthesis of corneal keratan sulfate proteoglycans by bovine keratocytes in vitro. J Biol Chem. 1996;271:31431-31436.
20. Beales MP, Funderburgh JL, Jester JV, Hassell JR. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40:1658-1663.
21. Funderburgh JL, Funderburgh ML, Mann MM, Corpuz L, Roth MR. Proteoglycan expression during transforming growth factor betainduced keratocyte-myofibroblast transdifferentiation 9. J Biol Chem. 2001;276:44173-44178.
22. Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis 6. J Biol Chem. 2003;278:45629-45637.
23. Chen J, Guerriero E, Sado Y, Sundar Raj N. Rho-mediated regulation of TGF-beta1-and FGF-2-induced activation of corneal stromal keratocytes. Invest Ophthalmol Vis Sci. 2009;50:3662-3670.
24. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans. 2005;33:891-895.
25. Atfi A, Djelloul S, Chastre E, Davis R, Gespach C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor betamediated signaling. J Biol Chem. 1997;272:1429-1432.
26. Shimada H, Rajagopalan LE. Rho-kinase mediates lysophosphatidic acid-induced IL-8 and MCP-1 production via p38 and JNK pathways in human endothelial cells. FEBS Lett. 2010;584: 2827-2832.
27. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996; 15:505-516.
28. Guerriero E, Chen J, Sado Y, et al. Loss of alpha3(IV) collagen expression associated with corneal keratocyte activation 3. Invest Ophthalmol Vis Sci. 2007;48:627-635.
29. Oike Y, Kimata K, Shinomura T, Nakazawa K, Suzuki S. Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-D-galactosidase (keratanase). Biochem J. 1980;191:193-207.
30. Chen J, Guerriero E, Lathrop K, Sundar Raj N. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression 1. Invest Ophthalmol Vis Sci. 2008;49:175-183.
31. Shirai H, Autieri M, Eguchi S. Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling. Curr Opin Nephrol Hypertens. 2007;16: 111-115.
32. Zhang L, Deng M, Kao CW, Kao WW, Xia Y. MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis. Mol Vis. 2003;9:584-593.
33. Chang Y, Wu XY. The role of c-Jun N-terminal kinases 1/2 in transforming growth factor beta(1)-induced expression of connective tissue growth factor and scar formation in the cornea. J Int Med Res. 2009;37:727-736.
34. Chang Y, Wu XY. JNK1/2 siRNA inhibits transforming-growth factor-beta1-induced connective tissue growth factor expression and fibrotic function in THSFs. Mol Cell Biochem. 2010; 335:83-89.
35. Jimenez B, Volpert OV, Reiher F, et al. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene. 2001;20:3443-3448.
36. Adhikary G, Sun Y, Pearlman E. C-Jun NH2 terminal kinase (JNK) is an essential mediator of Toll-like receptor 2-induced corneal inflammation. J Leukoc Biol. 2008;83:991-997.